Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholaas Honig

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|August 30, 2017
Addressing Pharmaceutical Injuries: The US LandscapeCecilia Bakker, Nicholaas Honig
Clinical Pharmacology and Therapeutics|August 8, 2023
SURF: A Screening Tool (for Sponsors) to Evaluate Whether Using Real-World Data to Support an Effectiveness Claim in an FDA Application Has Regulatory FeasibilityUlka B Campbell, Nicholaas Honig, Nicolle M Gatto
Clinical Pharmacology and Therapeutics|November 2, 2021
The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License ApplicationsChristina A Purpura, Elizabeth M Garry, Nicholaas Honig, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|August 30, 2017
Addressing Pharmaceutical Injuries: The US LandscapeCecilia Bakker, Nicholaas Honig
Clinical Pharmacology and Therapeutics|August 8, 2023
SURF: A Screening Tool (for Sponsors) to Evaluate Whether Using Real-World Data to Support an Effectiveness Claim in an FDA Application Has Regulatory FeasibilityUlka B Campbell, Nicholaas Honig, Nicolle M Gatto
Clinical Pharmacology and Therapeutics|November 2, 2021
The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License ApplicationsChristina A Purpura, Elizabeth M Garry, Nicholaas Honig, et al.
Pageof 1